Form 4: Director Esteban Lopez Receives Addus HomeCare Equity Grant

Addus HomeCare Corporation director Esteban Lopez was granted 1,449 restricted shares of common stock.

Summary

• Director Esteban Lopez acquired 1,449 shares of Addus HomeCare Corp (ADUS) common stock.
• The transaction occurred on June 10, 2026.
• The shares were granted as restricted stock units with a zero-dollar acquisition price.
• Following this transaction, the director's total beneficial ownership increased to 4,649 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which is neutral in terms of immediate market impact.

Positives

• Alignment of director interests with shareholders through equity-based compensation.
• Increase in total beneficial ownership by a member of the board.

Negatives

• None identified.

Risks

• Vesting risk: The shares are subject to a one-year cliff vesting period ending June 10, 2027.

Future Outlook

The restricted shares are scheduled to vest in full on June 10, 2027.

Industry Context

StockSavvy.ai notes that equity grants to non-employee directors are standard corporate governance practice in the healthcare services sector to ensure long-term alignment with shareholder value.

Comparison to Industry Standards

• The grant of restricted stock to directors is consistent with standard compensation practices for mid-cap healthcare companies.
• The one-year vesting schedule is typical for annual director equity retainers.

Stakeholder Impact

• Shareholders: Minimal impact; reflects standard director compensation.

Next Steps

• Vesting of the 1,449 restricted shares on June 10, 2027.

Key Dates

Keywords

Addus HomeCare, ADUS, Form 4, Insider Transaction, Equity Grant, Director Compensation